The efficient construction of all-carbon quaternary centers (Cq's) remains a challenge for the modern synthetic chemist.^[@ref1]^ The difficulty associated with forming Cq's arises from the inherent steric congestion during the C--C bond-forming event. Toward this end, our laboratory disclosed the first palladium-catalyzed enantioselective decarboxylative allylic alkylation for the construction of Cq's.^[@ref2]^ Over the past decade, we have continued to explore the breadth of our reaction manifold,^[@ref3]^ including the development of new ligands based on the original phosphinooxazoline (PHOX) scaffold.^[@ref4]^ Cyclic ketones generally represent the most explored class of substrates, from the initially reported cyclohexanones ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}A),^[@ref2],[@ref5]^ cycloheptanones,^[@ref2],[@cit3d],[@cit5b],[@cit5c]^ and cyclooctanones^[@ref2],[@cit3d],[@cit5b]^ to the more recently disclosed and highly strained cyclobutanones ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}B).^[@ref6]^
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Contrastingly, cyclopentanones have typically performed worse than the corresponding 6-membered substrates, often furnishing the α-Cq ketone products in comparatively reduced yields and enantiomeric excess (ee).^[@cit3d]^ Only a few examples with limited substrate scope exist for the formation of α-Cq cyclopentanones by transition-metal-catalyzed enantioselective allylic alkylation.^[@ref7]^ However, cyclopentanes containing enantioenriched Cq's characterize a number of biologically pertinent and chemically fascinating natural products, including polycyclic terpenoids **7**,^[@ref8]^**8**,^[@ref9]^ and **9**([@ref10]) as well as alkaloids **10**,^[@ref11]^**11**,^[@ref11]^ and **12**([@ref12]) ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}). As part of our continued efforts to extend the utility of our reaction methodology, we revisited the problematic cyclopentanone substrate class, striving to develop the first general method for the construction of α-Cq cyclopentanones and 5-membered cyclic ketone substrates by transition metal-catalyzed enantioselective decarboxylative allylic alkylation ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}C).

![Natural products characterized by cyclopentane rings containing chiral all-carbon quaternary centers (Cq's).](ol-2015-02376h_0006){#fig1}

Initial reaction development employed *p*-Me-benzyl-substituted β-ketoester **13a**, using catalytic Pd~2~(dba)~3~ at 20 °C in toluene in the presence of a chiral PHOX ligand, affording enantioenriched α-Cq cyclopentanone **14a** ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}).^[@ref13],[@ref14]^ Using the classic (*S*)-*t*-BuPHOX ligand (**(*****S*****)-L1**), cyclopentanone **(*****S*****)-14a** was provided in 87% ee (entry 1). Switching to the electron-deficient (*S*)-(*p*-CF~3~)~3~-*t*-BuPHOX (**(*****S*****)-L2**) furnished product **(*****S*****)-14a** in an improved 89% ee (entry 2). The recently disclosed, cost-effective alternative to **L2**, (*R*)-(*p*-CF~3~)~3~-*i*-PrPHOX^Me2^ (**(*****R*****)-L3**), provided cyclic ketone **(*****R*****)-14a** in a decreased 83% ee (entry 3).^[@cit4a]^ Similarly to **(*****R*****)-L3**, geminally disubstituted valine-derived (*S*)-(*p*-CF~3~)~2~-*i*-PrPHOX^Ph2^ (**(*****S*****)-L4**) afforded ketone **(*****S*****)-14a** with nearly equivalent ee (82%, entry 4). Switching to ester-substituted β-ketoester **13b**, we confirmed (*S*)-(*p*-CF~3~)~3~-*t*-BuPHOX (**(*****S*****)-L2**) was indeed the optimal ligand for the desired enantioselective decarboxylative allylic alkylation, providing enantioenriched α-Cq cyclopentanone **(*****S*****)-14b** in 91% ee (entry 6). The remaining PHOX ligands **(*****S*****)-L1**, **(*****R*****)-L3**, and **(*****S*****)-L4** furnished the desired product (**14b**) in reduced ee's, ranging between 80% and 82% (entries 5, 7, and 8, respectively).

###### PHOX Ligand Screen[a](#t1fn1){ref-type="table-fn"}
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Conditions: β-ketoester **13** (0.19 mmol), Pd~2~(dba)~3~ (2.75 mol %), ligand (6.00 mol %), toluene (5.8 mL).

Measured by analytical chiral SFC.

Having identified the optimal ligand for the enantioselective decarboxylative allylic alkylation, we next examined the solvent effect using β-ketoester **13b** ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). Employing identical reaction conditions from our ligand screen, using toluene as the solvent, we isolated α-Cq cyclopentanone **(*****S*****)-14b** in 91% ee, achieving complete consumption of starting material **13b** in 8.0 h (entry 1). Switching to the less polar solvent mixture 2:1 hexanes/toluene, which has previously provided increased ee's for other α-Cq cyclic ketones constructed through palladium-catalyzed enantioselective decarboxylative allylic alkylation,^[@ref15]^ did not affect the reaction time but furnished ketone **(*****S*****)-14b** in a diminished 88% ee (entry 2). Changing to ethereal solvents (entries 3 and 4) drastically decreased the reaction time, facilitating the full consumption of β-ketoester **13b** in 1.0 h. While the use of MTBE (entry 3) afforded cyclopentanone **(*****S*****)-14b** in nearly identical ee to the mixed nonpolar solvent system (entry 2), switching to THF (entry 4) proved deleterious. Ultimately, the use of Pd~2~(dba)~3~ (2.75 mol %) with (*S*)-(*p*-CF~3~)~3~-*t*-BuPHOX (**(*****S*****)-L2**, 6.00 mol %) in toluene (0.033 M in β-ketoester **13b**) at 20 °C proved optimal.

###### Solvent Effect on Enantiomeric Excess of Cyclopentanone Product (*S*)-**14b**[a](#t2fn1){ref-type="table-fn"}
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  entry   solvent              time (h)   ee[b](#t2fn2){ref-type="table-fn"} (%)
  ------- -------------------- ---------- ----------------------------------------
  1       toluene              8.0        91
  2       2:1 hexane/toluene   8.0        88
  3       MTBE                 1.0        87
  4       THF                  1.0        81

Conditions: β-ketoester **13b** (0.19 mmol), Pd~2~(dba)~3~ (2.75 mol %), **(*****S*****)-L2** (6.00 mol %), toluene (5.8 mL).

Measured by analytical chiral SFC.

Subsequently, we explored the substrate scope of the enantioselective allylic alkylation of cyclopentanones. We found that our reaction manifold was tolerant of a variety of substitution at the α-position of the cyclopentanone ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}).^[@ref16]^ Alkyl-substituted α-Cq cyclopentanones **(*****S*****)-14c**, **(*****S*****)-14d**, and **(*****S*****)-14e** were each produced over reaction times greater than 30 h with ee's ranging from 86% to 88%, providing the more sterically congested cyclopentanone **(*****S*****)-14e** over a slightly longer reaction time.^[@ref13]^ Along with ester-substituted cyclopentanone **(*****S*****)-14b**, nitrile **(*****S*****)-14f** and phthalamide **(*****S*****)-14g** were both produced quite rapidly at 20 °C in excellent yield with good ee (2.5 h, 97% yield, 87% ee and 3.0 h, 93% yield, 88% ee, respectively). We found that we could increase the ee of these two products significantly by lowering the temperature without any deleterious effect on the yield, providing cyclopentanones **(*****S*****)-14f** and **(*****S*****)-14g** in an improved 90% ee and 93% ee, respectively, at 0 °C over 23.0 h. This result represents a dramatic improvement in the formation of **(*****S*****)-14g** compared to our previously reported system, employing THF as the solvent with **(*****S*****)-L1** as the ligand, which provided **(*****S*****)-14g** in only 67% yield with 48% ee.^[@cit3d]^ Comparatively, benzyl-substituted cyclopentanones proved to have a correlation between the electronics of the aryl substituent and the overall reaction time. Electron rich *p*-OMe-benzyl cyclopentanone **(*****S*****)-14h** was furnished in only 8.0 h, while the electron-neutral benzyl and *p*-Me-benzyl products (**(*****S*****)-14i** and **(*****S*****)-14a**) were each provided over a slightly extended reaction time (13.0 h). Contrastingly, the reaction producing electron poor *p*-CF~3~-benzyl-substitued **(*****S*****)-14j** failed to proceed to full conversion over 96.0 h, affording the product in a reduced 56% overall yield (83% yield based on recovered β-ketoester). Interestingly, despite the variable reaction times, the ee of the benzyl-substituted cyclopentanone products was largely consistent (88%--89% ee), with a slight boost for the electron-rich *p*-OMe-benzyl product (**(*****S*****)-14h**) to 92% ee.

![Substrate Scope of Cyclopentanone Substitution in Enantioselective Allylic Alkylation\
Unless otherwise noted, all reported yields are isolated yields. Enantiomeric excess (ee) was determined by either analytical chiral SFC or HPLC.\
Conditions: β-ketoester **13** (0.19 mmol), Pd~2~(dba)~3~ (2.75 mol %), **(*****S*****)-L2** (6.00 mol %), toluene (5.8 mL).\
Cyclopentanone product was volatile, resulting in a reduced isolated yield compared to other substrates.\
Reaction performed at 0 °C.\
Yield reported based on recovered β-ketoester starting material. Isolated yield was 56%.](ol-2015-02376h_0008){#sch2}

Additionally, we found that indanones were competent substrates within our reaction manifold ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}).^[@cit3d],[@cit5a],[@cit5d],[@cit7g]^ Methyl-substituted indanone product **(*****S*****)-16a** was furnished over a greatly shortened 4.5 h compared to the methyl-substituted cyclopentanone product (**(*****S*****)-14c**, see [Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}). Additionally, bicycle **(*****S*****)-16a** was provided in 94% yield with 84% ee. Comparatively, the fluorinated analog **(*****S*****)-16b** was produced in an improved \>99% yield and 87% ee, albeit over a longer reaction time (13.0 h).

![Enantioselective Allylic Alkylation of Indanone Substrates](ol-2015-02376h_0009){#sch3}

Having investigated the tolerance of our reaction manifold to a variety of substitutions on the cyclopentanone ring, we next evaluated the potential to use 2-substituted allyl fragments in the enantioselective allylic alkylation of cyclopentanones ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}). Methyl- and ethyl-substituted cyclopentanone products **(*****S*****)-6a** and **(*****S*****)-6b** containing a 2-phenylallyl fragment were both produced in excellent yield and with 90% and 94% ee, respectively. Comparatively, cyclopentanones **(*****S*****)-6c** and **(*****S*****)-6d**, each containing a 2-chloroallyl fragment, were produced with similar ee's in slightly reduced yield. Interestingly, each of the alkyl-substituted cyclopentanone products possessing a 2-substituted allyl fragment were produced over a shorter reaction time than the same substrates containing an unsubstituted allyl fragment (see [Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}).

![Enantioselective Allylic Alkylation of Cyclopentanone Substrates with 2-Substituted Allyl Fragments.\
All reported yields are isolated yields. Enantiomeric excess (ee) was determined by analytical chiral SFC.\
Conditions: β-ketoester **5** (0.19 mmol), Pd~2~(dba)~3~ (2.75 mol %), **(*****S*****)-L2** (6.00 mol %), toluene (5.8 mL).](ol-2015-02376h_0010){#sch4}

Lastly, we examined the potential to apply our recently disclosed palladium(II) low catalyst loading protocol for enantioselective decarboxylative allylic alkylation to this new substrate class.^[@ref17]^ We discovered that on a small scale, ester-substituted cyclopentanone **(*****S*****)-14b** was provided in an identical 91% ee and an improved 98% yield at 20 °C using only 0.15 mol % palladium catalyst ([Scheme [5](#sch5){ref-type="scheme"}](#sch5){ref-type="scheme"}) compared to our palladium(0)-mediated reaction conditions, which employ 5.50 mol % palladium (vide supra). Increasing the scale of the reaction slightly (0.22 mmol) as well as the temperature (28 °C) and catalyst loading (0.30 mol % Pd) furnished **(*****S*****)-14b** over a reduced 18 h in 96% yield with 89% ee. Using these reaction conditions and increasing the scale 17 times (3.73 mmol) provided **(*****S*****)-14b** with identical 89% ee, although in a slightly diminished 82% yield.

![Low Catalyst Loading Palladium(II)-Mediated Enantioselective Allylic Alkylation\
All reported yields are isolated yields. Enantiomeric excess (ee) was determined by analytical chiral SFC.\
Pd(OAc)~2~ (0.15 mol %), **(*****S*****)-L2** (1.50 mol %) used.](ol-2015-02376h_0001){#sch5}

In conclusion, we have disclosed the first general method for the construction of α-Cq cyclopentanones by enantioselective palladium-catalyzed decarboxylative allylic alkylation. The reaction manifold proved optimal when electron-deficient (*S*)-(*p*-CF~3~)~3~-*t*-BuPHOX (**(*****S*****)-L2**) was employed, providing a variety of substituted cyclopentanone products in up to near-quantitative yield and with up to 94% ee. Additionally, the enantioselective allylic alkylation was found to be tolerant of allyl fragments substituted at the 2-position. Use of low-catalyst loading, palladium(II)-mediated reaction conditions was successfully accomplished, facilitating the synthesis of α-Cq cyclopentanones on increased scale in a cost-effective manner. Currently, our laboratory is pursuing further development of this technology through substrate scope extension and application in natural product synthesis.
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